IN2014DN01612A - - Google Patents

Info

Publication number
IN2014DN01612A
IN2014DN01612A IN1612DEN2014A IN2014DN01612A IN 2014DN01612 A IN2014DN01612 A IN 2014DN01612A IN 1612DEN2014 A IN1612DEN2014 A IN 1612DEN2014A IN 2014DN01612 A IN2014DN01612 A IN 2014DN01612A
Authority
IN
India
Prior art keywords
components
situ
spraying
matrix
course
Prior art date
Application number
Other languages
English (en)
Inventor
Carsten Rudolph
Senta Üzgün
Original Assignee
Ethris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethris Gmbh filed Critical Ethris Gmbh
Publication of IN2014DN01612A publication Critical patent/IN2014DN01612A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015Drug-containing film-forming compositions, e.g. spray-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/713Double-stranded nucleic acids or oligonucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A61K48/0041Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being polymeric

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IN1612DEN2014 2011-09-28 2012-09-25 IN2014DN01612A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102011114986A DE102011114986A1 (de) 2011-09-28 2011-09-28 Sprühsystem
PCT/EP2012/068889 WO2013045455A1 (de) 2011-09-28 2012-09-25 Sprühsystem zur erzeugung einer in situ gebildeten matrix

Publications (1)

Publication Number Publication Date
IN2014DN01612A true IN2014DN01612A (de) 2015-05-15

Family

ID=46924442

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1612DEN2014 IN2014DN01612A (de) 2011-09-28 2012-09-25

Country Status (12)

Country Link
US (1) US20140243395A1 (de)
EP (1) EP2760437A1 (de)
JP (1) JP2014527886A (de)
KR (1) KR20140068089A (de)
AU (1) AU2012314512A1 (de)
BR (1) BR112014007443A2 (de)
CA (1) CA2850253A1 (de)
DE (1) DE102011114986A1 (de)
EA (1) EA026717B1 (de)
IN (1) IN2014DN01612A (de)
WO (1) WO2013045455A1 (de)
ZA (1) ZA201401557B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3004331A1 (de) * 2013-06-05 2016-04-13 Fundación Pública Andaluza Progreso Y Salud Verwendung von mesothelialen zellen in einem gewebe-bioengineering und in künstlichen geweben
US12064484B2 (en) 2013-06-28 2024-08-20 Ethris Gmbh Compositions for introducing RNA into cells
JP2017507946A (ja) 2014-02-26 2017-03-23 エスリス ゲーエムベーハーethris GmbH Rnaを胃腸内投与するための組成物
US9655842B1 (en) 2015-12-04 2017-05-23 Covidien Lp Injectable non-aqueous compositions and methods of treating vascular disease
US11013501B2 (en) 2017-12-08 2021-05-25 Davol, Inc. Method of protecting the peritoneum against tearing and other injury before an active surgical intervention at or near the peritoneum
EP3628309A1 (de) * 2018-09-28 2020-04-01 Universität Heidelberg Verfahren zur herstellung oraler dosierungsformen
ES3030742A1 (es) * 2023-12-28 2025-07-01 Univ Sevilla Procedimiento de preparación de nanopartículas poliméricas de PLGA

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8815435D0 (en) * 1988-06-29 1988-08-03 Smith & Nephew Non autoadherent dressings
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
TW247878B (de) * 1991-07-02 1995-05-21 Takeda Pharm Industry Co Ltd
EP0560014A1 (de) * 1992-03-12 1993-09-15 Atrix Laboratories, Inc. Biologisch abbaubarer Wundverband in Form eines Sprühfilms und Verfahren zu seiner Herstellung
US6733767B2 (en) * 1998-03-19 2004-05-11 Merck & Co., Inc. Liquid polymeric compositions for controlled release of bioactive substances
PT1063942E (pt) * 1998-03-19 2004-10-29 Merck & Co Inc Composicoes polimericas liquidas para libertacao controlada de substancias bioactivas
US6103266A (en) * 1998-04-22 2000-08-15 Tapolsky; Gilles H. Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
JP4540762B2 (ja) 1999-01-18 2010-09-08 本田技研工業株式会社 排気2次空気弁を備えた鞍乗型車両
CN1684663A (zh) 2002-07-31 2005-10-19 阿尔萨公司 可注射的多模式聚合物储库组合物以及其用途
AU2004313245B2 (en) 2003-12-30 2011-04-14 Durect Corporation Polymeric implants, preferably containing a mixture of PEG and PLG, for controlled release of active agents, preferably a GNRH
US8097239B2 (en) * 2005-06-06 2012-01-17 Camurus Ab Controlled-release formulations
JP2009533455A (ja) * 2006-04-12 2009-09-17 マサチューセッツ インスティテュート オブ テクノロジー 癒着を阻害するための組成物および方法
WO2010142660A2 (en) * 2009-06-09 2010-12-16 Novartis Ag Drug delivery system
US9649331B2 (en) 2009-08-27 2017-05-16 Ara Medical Llc Sprayable polymers as adhesion barriers

Also Published As

Publication number Publication date
EP2760437A1 (de) 2014-08-06
AU2012314512A1 (en) 2014-03-20
KR20140068089A (ko) 2014-06-05
EA026717B1 (ru) 2017-05-31
EA201400388A1 (ru) 2014-08-29
ZA201401557B (en) 2015-09-30
CN103930097A (zh) 2014-07-16
DE102011114986A1 (de) 2013-03-28
JP2014527886A (ja) 2014-10-23
BR112014007443A2 (pt) 2017-04-04
US20140243395A1 (en) 2014-08-28
CA2850253A1 (en) 2013-04-04
WO2013045455A1 (de) 2013-04-04

Similar Documents

Publication Publication Date Title
IN2014DN01612A (de)
WO2012018446A3 (en) Anchor delivery system
WO2012091952A3 (en) Median lobe retraction apparatus and method
WO2011112248A3 (en) Methods and devices for real time monitoring of collagen and for altering collagen status
WO2012091956A3 (en) Continuous indentation lateral lobe apparatus and method
MX2017017090A (es) Compuestos derivados de sulfamida de 1,3,4-oxadiazol como inhibidor de histona desacetilasa 6, y la composicion farmaceutica que comprende los mismos.
GB201019577D0 (en) Method
EP3808367A3 (de) Abzielung auf aneurysma durch modulation von phagozytosesignalwegen
EP4461326A3 (de) Flexibles system zur freisetzung eines ankers
WO2012091954A3 (en) Median lobe destruction apparatus and method
NZ611606A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
WO2012091955A3 (en) Median lobe band implant apparatus and method
PH12016500866A1 (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
MY167691A (en) A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
WO2016113550A3 (en) Dressing
MX2013002932A (es) Formulaciones agricolas liquidas de estabilidad mejorada.
WO2014093489A3 (en) Hydrogel membrane for adhesion prevention
EP4477157A3 (de) Expandierbare gewebeeingriffsvorrichtung
HK1198921A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof
WO2014104974A3 (en) Self-assembling ultrashort peptides modified with bioactive agents by click chemistry
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
EP3606570B8 (de) Arzneizusammensetzungen auf der basis von kollagenpeptid zur verwendung in der behandlung augenkrankheiten, -störungen oder -wunden
WO2012109535A3 (en) Amino acid derivatives and absorbable polymers therefrom
EP2407147A3 (de) Zusammensetzung mit biologisch regenerativer, restaurativer und eutrophierender Aktivität
HK1216839A1 (zh) 调整释放制剂